Sandoz Takes Zero-Profit Approach To COVID-19 In Africa
As mAbxience Partners With AstraZeneca To Produce Oxford Vaccine
As Sandoz tries to assist African Union member states by selling its pandemic response portfolio medicines for zero profit, mAbxience has partnered with AstraZeneca to produce a vaccine. And CDMO Hovione has struck a deal with Ligand to boost manufacturing of Captisol, a critical ingredient for Gilead’s remdesivir.
